{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:57:32Z","timestamp":1790737052328,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003997","name":"Vrienden UMC Utrecht","doi-asserted-by":"publisher","award":["1522166"],"award-info":[{"award-number":["1522166"]}],"id":[{"id":"10.13039\/501100003997","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejca.2025.115278","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T11:07:41Z","timestamp":1738408061000},"page":"115278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Optimal timing for initiating first-line palliative systemic therapy in asymptomatic metastatic esophagogastric cancer: Insights from a European Delphi study"],"prefix":"10.1016","volume":"218","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9118-4731","authenticated-orcid":false,"given":"Denice","family":"Kamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0643-3790","authenticated-orcid":false,"given":"Anne M.","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3123-9746","authenticated-orcid":false,"given":"Antoine","family":"Adenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7576-6938","authenticated-orcid":false,"given":"Andreia","family":"Capela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Derks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"De Felice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5979-1404","authenticated-orcid":false,"given":"Nina Fokter","family":"Dovnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinta","family":"Hierro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8291-0873","authenticated-orcid":false,"given":"Aysegul","family":"Ilhan-Mutlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8591-9339","authenticated-orcid":false,"given":"Florian","family":"Lordick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radka Lordick","family":"Obermannova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5489-5733","authenticated-orcid":false,"given":"Angelica","family":"Petrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2492-4043","authenticated-orcid":false,"given":"Alberto","family":"Puccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Raimundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giandomenico","family":"Roviello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5404-2383","authenticated-orcid":false,"given":"Alexander","family":"Siebenh\u00fcner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marije","family":"Slingerland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke W.M.","family":"van Laarhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4688-2921","authenticated-orcid":false,"given":"Nadia Haj","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ejca.2025.115278_bib1","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/ijc.32580","article-title":"Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: a real-world evidence study","volume":"146","author":"Dijksterhuis","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2025.115278_bib2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejca.2018.02.025","article-title":"Long-term survival improvement in oesophageal cancer in the Netherlands","volume":"94","author":"van Putten","year":"2018","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.ejca.2025.115278_bib3","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/bjs\/znac290","article-title":"Population-based study of treatment and outcome of recurrent oesophageal or junctional cancer","volume":"109","author":"Pape","year":"2022","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejca.2025.115278_bib4","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221085557","article-title":"A population-based study in synchronous versus metachronous metastatic esophagogastric adenocarcinoma","volume":"14","author":"Pape","year":"2022","journal-title":"Ther Adv Med Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2025.115278_bib5","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","article-title":"Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Lordick","year":"2022","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2025.115278_bib6","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.annonc.2022.07.003","article-title":"Oesophageal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Obermannova","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2025.115278_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejca.2022.08.023","article-title":"Recent progress and current challenges of immunotherapy in advanced\/metastatic esophagogastric adenocarcinoma","volume":"176","author":"Moehler","year":"2022","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.ejca.2025.115278_bib8","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1002\/cncr.25064","article-title":"Impact of chemotherapy on quality of life in patients with metastatic esophagogastric cancer","volume":"116","author":"Al-Batran","year":"2010","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.ejca.2025.115278_bib9","first-page":"CD004064","article-title":"Chemotherapy for advanced gastric cancer","author":"Wagner","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.ejca.2025.115278_bib10","first-page":"CD004063","article-title":"Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer","author":"Janmaat","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"22","key":"10.1016\/j.ejca.2025.115278_bib11","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1002\/cncr.27550","article-title":"A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer","volume":"118","author":"Smyth","year":"2012","journal-title":"Cancer"},{"issue":"18","key":"10.1016\/j.ejca.2025.115278_bib12","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1200\/JCO.2000.18.18.3202","article-title":"Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma","volume":"18","author":"Flamen","year":"2000","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.ejca.2025.115278_bib13","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa2032125","article-title":"Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer","volume":"384","author":"Kelly","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2025.115278_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyad235","article-title":"Delayed versus immediate start of chemotherapy in asymptomatic patients with advanced cancer: a meta-analysis","author":"Augustinus","year":"2023","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.ejca.2025.115278_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000434647","article-title":"Early versus delayed therapy of advanced gastric cancer patients-does it make a difference?","volume":"89","author":"Elimova","year":"2015","journal-title":"Oncology"},{"issue":"1","key":"10.1016\/j.ejca.2025.115278_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/1937586719887709","article-title":"We agree, don't We? The Delphi method for health environments research","volume":"13","author":"Taylor","year":"2020","journal-title":"HERD"},{"issue":"4","key":"10.1016\/j.ejca.2025.115278_bib17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2013.12.002","article-title":"Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies","volume":"67","author":"Diamond","year":"2014","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"10.1016\/j.ejca.2025.115278_bib18","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/0269216317690685","article-title":"Guidance on conducting and reporting delphi studies (CREDES) in palliative care: Recommendations based on a methodological systematic review","volume":"31","author":"Junger","year":"2017","journal-title":"Palliat Med"},{"issue":"4","key":"10.1016\/j.ejca.2025.115278_bib19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.6004\/jnccn.2020.7631","article-title":"SOURCE: prediction models for overall survival in patients with metastatic and potentially curable esophageal and gastric cancer","volume":"19","author":"van den Boorn","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ejca.2025.115278_bib20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejca.2023.02.015","article-title":"Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: a Delphi consensus study in Europe","volume":"185","author":"Kroese","year":"2023","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2025.115278_bib21","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/ijc.34780","article-title":"Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival","volume":"154","author":"Rijken","year":"2024","journal-title":"Int J Cancer"},{"issue":"10294","key":"10.1016\/j.ejca.2025.115278_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"issue":"9742","key":"10.1016\/j.ejca.2025.115278_bib23","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.ejca.2025.115278_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15235603","article-title":"Timing of initiation of palliative chemotherapy in asymptomatic patients with metastatic pancreatic cancer: an international expert survey and case-vignette study","volume":"15","author":"Augustinus","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ejca.2025.115278_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/1097-0142(19950101)75:1<11::AID-CNCR2820750104>3.0.CO;2-N","article-title":"Age and sex are independent predictors of 5-fluorouracil toxicity. Analysis of a large scale phase III trial","volume":"75","author":"Stein","year":"1995","journal-title":"Cancer"},{"issue":"4 2","key":"10.1016\/j.ejca.2025.115278_bib26","first-page":"18","article-title":"Greater risks of chemotherapy toxicity in elderly patients with cancer","volume":"1","author":"Repetto","year":"2003","journal-title":"J Support Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2025.115278_bib27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s12094-019-02167-y","article-title":"Management of the toxicity of chemotherapy and targeted therapies in elderly cancer patients","volume":"22","author":"Feliu","year":"2020","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2025.115278_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jgo.2020.08.001","article-title":"Shared decision-making in older patients with cancer - what does the patient want?","volume":"12","author":"Rostoft","year":"2021","journal-title":"J Geriatr Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2025.115278_bib29","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/jamaoncol.2021.0848","article-title":"Efficacy of reduced-intensity chemotherapy with oxaliplatin and capecitabine on quality of life and cancer control among older and frail patients with advanced gastroesophageal cancer: the GO2 phase 3 randomized clinical trial","volume":"7","author":"Hall","year":"2021","journal-title":"JAMA Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2025.115278_bib30","doi-asserted-by":"crossref","first-page":"e1324","DOI":"10.1093\/oncolo\/oyae087","article-title":"Health-related quality-of-life analysis from KEYNOTE-590: pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer","volume":"29","author":"Mansoor","year":"2024","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.ejca.2025.115278_bib31","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1634\/theoncologist.2014-0058","article-title":"Quality of life in the trastuzumab for gastric cancer trial","volume":"19","author":"Satoh","year":"2014","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.ejca.2025.115278_bib32","first-page":"12","article-title":"Quality of life during palliative systemic therapy for esophagogastric cancer: systematic review and meta-analysis","volume":"112","author":"van Kleef","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.ejca.2025.115278_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-076798","article-title":"Trade-offs between overall survival and side effects in the treatment of metastatic breast cancer: eliciting preferences of patients with primary and metastatic breast cancer using a discrete choice experiment","volume":"14","author":"Bullen","year":"2024","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.ejca.2025.115278_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jviscsurg.2013.10.001","article-title":"Endpoints in cancer clinical trials","volume":"151","author":"Fiteni","year":"2014","journal-title":"J Visc Surg"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925000590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925000590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:36:06Z","timestamp":1777350966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804925000590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":34,"alternative-id":["S0959804925000590"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2025.115278","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal timing for initiating first-line palliative systemic therapy in asymptomatic metastatic esophagogastric cancer: Insights from a European Delphi study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2025.115278","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"115278"}}